top of page

June 2026: Healthcare M&A Snapshot

  • Jul 3
  • 2 min read
A summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in June 2026

View our summary of the key M&A, private equity and venture capital deals across the UK healthcare sector in June 2026 below.



Notable Sector Deals: June 2026


Chariot Capital Group’s acquisition of Laser Clinics UK


  • A carve-out acquisition for Chariot Capital Group, acquiring Laser Clinics UK from Laser Clinics Group, a KKR portfolio company

  • Laser Clinics UK is one of the UK’s leading laser, skin and aesthetics treatment providers, operating more than 40 clinics across the UK

  • The business offers laser hair removal, cosmetic injectables and a range of skin treatments through a clinician-led, franchise-partnership model

  • Chariot is acquiring the UK business as a standalone platform and plans to support further growth through investment in the clinic network, technology platform and talent base


Person Centred Software’s acquisition of Camascope


  • A strategic acquisition for Person Centred Software, acquiring Camascope, a digital medication management provider for the social care sector

  • The deal combines PCS’s digital care planning platform with Camascope’s eMAR medication management solution

  • Camascope supports more than 85,000 care residents, having grown significantly in recent years

  • Following the transaction, Kehan Zhou has been appointed Group CEO of PCS, Camascope and Clearcare

  • The deal highlights continued appetite for social care software assets, particularly where platforms can support safer, more connected care delivery


Acquisition of Glenholme Specialist Care by STAR Capital


  • A significant investment for STAR Capital, acquiring Glenholme Specialist Care

  • Glenholme provides specialist care services for working-age adults with learning disabilities, autism, ABI and other complex needs

  • The business operates 22 specialist services across England, including supported living, residential care and outreach services

  • The deal fits STAR’s focus on essential services, with Glenholme offering long-stay, non-cyclical and asset-backed care services

  • The transaction highlights continued investor appetite for specialist adult social care, particularly where providers combine strong care quality, resilient demand and freehold-backed locations


Sofina’s investment in Creature Comforts


  • A growth investment from Sofina into Creature Comforts, a fast-growing veterinary care provider founded in 2022

  • Creature Comforts operates a modern veterinary clinic platform, built around transparent pricing, a subscription-based membership model and digitally enabled customer experience

  • The business currently operates 12 clinics, with a further two expected to open shortly

  • The investment will support the next phase of growth, including new clinic openings, development of the technology platform, 24-hour care, advanced imaging and specialty services


Healthcare Market Activity: June 2026


Private Equity Activity


Sub-sector

Target

Acquirer / Investor

Exiting PE

Aesthetics

Laser Clinics UK

Chariot Capital Group

KKR

Digital Health

Camascope

PCS

(Cow Corner)

N/A

Elderly Care

Forest Gate Healthcare

Oakwood Care

(Dev Bank of Wales)

N/A

Pharma Services

Oxford PharmaGenesis

Klick Health

(Linden / GIC)

N/A

Specialist Care

Glenholme

Specialist Care

STAR Capital Partnership

N/A

Training

Flick Learning

Impact Futures

(August)

N/A

Veterinary

Creature Comforts

Sofina

N/A

Veterinary

Knaphill Vets

Kin Vet

(Perwyn)

N/A


Venture Capital Activity


Target

Description

Lead Investor

Investment

Flok Health

AI operated physio clinic

Albion VC

£9.5m

Frontier Health

AI assistant for NHS admin teams

Atomico

$16m

Gnosis Health

AI assistant for Parkinson’s disease patients

SFC Capital

Northstar Ventures

£1.1m

Houdini Bio

DNA design platform for gene and cell therapy durability

SCVC

£1.5m

Silveray

X-ray technology

PXN Ventures

£5m

TRIMTECH Therapeutics

Targeted protein degradation portfolio

JJDC

$14m


 
 
 

Comments


Eclipse Corporate Finance Limited is a limited company registered in England & Wales (registered number 11791669)

The company is regulated by the Institute of Chartered Accountants of Scotland for a range of investment business activities 

  • LinkedIn
bottom of page